Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15949765 | 0.97 | TSHR (0.52) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| SCHEMBL984292 | 0.95 | TSHR (0.58) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| SCHEMBL985818 | 0.94 | TSHR (0.56) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| SCHEMBL17063040 | 0.94 | TSHR (0.56) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| SCHEMBL3611978 | 0.90 | TSHR (0.48) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| SCHEMBL9615807 | 0.85 | MEN1 (0.45) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| SCHEMBL1307986 | 0.84 | ALDH1A1 (0.39) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| SCHEMBL16319601 | 0.83 | ALDH1A1 (0.38) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| SCHEMBL28019470 | 0.83 | TSHR (0.50) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 | |
| Methacrylic Acid SCHEMBL7627265 | 0.81 | TSHR (0.62) | TSHRSMN1; SMN2ALDH1A1TDP1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9683150-B2 | Curable composition, adhesive, method of producing fiber-reinforced composite material, and fiber-reinforced composite material | TOKYO OHKA KOGYO CO., LTD. (JP) | 2017-06-20 | — | — | US | claimed |
| EP-2382315-B1 | NUCLEIC ACID PURIFICATION METHOD | QIAGEN GMBH (DE) | 2015-09-23 | — | — | EP | claimed |
| EP-2382315-A1 | NUCLEIC ACID PURIFICATION METHOD | Qiagen GmbH (DE) | 2011-11-02 | — | — | EP | claimed |
| WO-2010072834-A1 | NUCLEIC ACID PURIFICATION METHOD | QIAGEN GMBH (DE) | 2010-07-01 | — | — | WO | claimed |
| US-11685145-B2 | Flow path structure, liquid ejecting apparatus, liquid ejecting head, and method of manufacturing flow path structure | SEIKO EPSON CORPORATION (JP) | 2023-06-27 | — | — | US | disclosed |
| US-20230077371-A1 | CURABLE COMPOSITION, CURABLE INK, COMPOSITION CONTAINER, DEVICE FOR FORMING TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE, METHOD OF FORMING TWO-DIMENSIONAL OR THREE-DIMENSIONAL IMAGE, CURED MATTER, AND DECORATIVE OBJECT | RICOH COMPANY, LTD. (JP) | 2023-03-16 | — | — | US | disclosed |
| US-20220389308-A1 | WAVELENGTH CONVERSION FILM, WAVELENGTH CONVERSION FILM FORMING COMPOSITION, AND CLUSTER-CONTAINING QUANTUM DOT PRODUCTION METHOD | TOKYO OHKA KOGYO CO., LTD. (JP) | 2022-12-08 | — | — | US | disclosed |
| US-11338562-B2 | Antifogging laminate | MITSUI CHEMICALS, INC. (JP) | 2022-05-24 | — | — | US | disclosed |
| US-11174221-B2 | Aromatic amine compound, curing agent for epoxy compound, curable composition, cured product, method for producing cured product, and method for producing aromatic amine compound | TOKYO OHKA KOGYO CO., LTD. (JP) | 2021-11-16 | — | — | US | disclosed |
| EP-3729067-B1 | REFERENCE ELECTRODE FOR POTENTIOMETRIC MEASUREMENT OF ION CONCENTRATIONS | ERBA TECH AUSTRIA GMBH (AT) | 2021-11-03 | — | — | EP | disclosed |
| CN-110546207-B | Transparent resin composition, transparent coating film and transparent resin-coated glass substrate | 东丽株式会社 | 2021-10-08 | — | — | CN | disclosed |
| US-20210284862-A1 | Antireflective Laminate | MITSUI CHEMICALS, INC. (JP) | 2021-09-16 | — | — | US | disclosed |
| US-20080079796-A1 | INKJET RECORDING METHOD AND INKJET RECORDING APPARATUS | FUJIFILM CORPORATION (JP) | 2008-04-03 | — | — | US | disclosed |
| US-20080074482-A1 | Ink jet recording method and ink jet recording device | FUJIFILM CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| US-20070207412-A1 | Method of producing planographic printing plate, and planographic printing plate | FUJIFILM CORPORATION (JP) | 2007-09-06 | — | — | US | disclosed |
| US-20060194029-A1 | Ink composition, inkjet recording method using the same, and printed material | FUJI PHOTO FILM CO., LTD. | 2006-08-31 | — | — | US | disclosed |
| US-20060029750-A1 | Cellulose ester film, cellulose ester dope, protective film of polarizing plate and polarizing plate | KONICA CORPORATION | 2006-02-09 | — | — | US | disclosed |
| US-6974608-B2 | Cellulose ester film, cellulose ester dope, protective film of polarizing plate and polarizing plate | KONICA CORPORATION (JP) | 2005-12-13 | — | — | US | disclosed |
| US-20020102369-A1 | Cellulose ester film, cellulose ester dope, protective film of polarizing plate and polarizing plate | KONICA CORPORATION. | 2002-08-01 | — | — | US | disclosed |
| JP-2002128772-A | METHOD FOR PRODUCING 2-GLYCIDYLOXYETHYL(METH)ACRYLATE | MITSUBISHI RAYON CO LTD | 2002-05-09 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11174221-B2 | Aromatic amine compound, curing agent for epoxy compound, curable composition, cured product, method for producing cured product, and method for producing aromatic amine compound | SETDB1, DOT1L, KDM5B | TSHR 3496/4885SMN1; SMN2 2255/4885ALDH1A1 570/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.